In 2018, I received a diagnosis of type-2 diabetes, which prompted me to take control of my health through meticulous documentation. I began tracking my blood glucose levels, which were previously above the normal range of 74-100 mg/dL, with an HbA1C of 11.5%. At that time, I weighed 185 lbs and stood at 5 feet 11.5 inches. Already using Dr. Amy Lee’s BIO-X4 probiotic, a program led by a Nutritionist and Weight Management Specialist, I noticed a significant side benefit: my HbA1C plummeted to as low as 3.5%.
I consistently monitored my finger-stick blood glucose levels before breakfast, lunch, and dinner. On February 15th, I introduced Dr. Marlene Merritt’s Blood Glucose Formula (BGF) to assess its impact on my blood glucose levels. Remarkably, my pre-lunch and pre-dinner readings began to differentiate from my pre-breakfast (nocturnal) glucose measurements. This change was statistically significant, with pre-dinner levels separating faster, leading to the identification of a nocturnal and diurnal phase of diabetes.
Furthermore, I utilized the LibreLink technology to verify and expand upon my finger-stick data. Moving forward, it is essential to validate this single type-2 diabetes case study with a diverse group of ten patients (5 females and 5 males) and also extend the research to include non-diabetic and severe diabetic populations. This broader analysis will enhance our understanding of diabetes and the crucial role that glucose, a universal energy molecule found in every cell, plays in maintaining good health.
